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Background: Physiological interactions are abundant within, and between, body
systems. These interactions may evolve into discrete states during pathophysiological
processes resulting from common mechanisms. An association between arterial
stenosis, identified by low ankle-brachial pressure index (ABPI) and cardiovascular
disease (CVD) as been reported. Whether an association between vascular
calcification—characterized by high ABPI and a different pathophysiology—is similarly
associated with CVD, has not been established. The current study aims to investigate
the association between ABPI, and cardiac rhythm, as an indicator of cardiovascular
health and functionality, utilizing heart rate variability (HRV).
MethodsandResults:Twohundred and thirty six patients underwent ABPI assessment.
Standard time and frequency domain, and non-linear HRV measures were determined
from5-min electrocardiogram. ABPI datawere divided into normal (n = 101), low (n = 67)
and high (n = 66) and compared toHRVmeasures.(DFAα1 andSampEnwere significantly
different between the low ABPI, high ABPI and control groups (p < 0.05).
Conclusion: Apossible coupling between arterial stenosis and vascular calcificationwith
decreased and increased HRV respectively was observed. Our results suggest a model
for interpreting the relationship between vascular pathophysiology and cardiac rhythm.
The cardiovascular system may be viewed as a complex system comprising a number
of interacting subsystems. These cardiac and vascular subsystems/networks may be
coupled and undergo transitions in response to internal or external perturbations. From
a clinical perspective, the significantly increased sample entropy compared to the normal
ABPI group and the decreased and increased complex correlation properties measured
byDFA for the low and high ABPI groups respectively,may be useful indicators that amore
holistic treatment approach in line with this more complex clinical picture is required.
Keywords: network physiology, complex systems, ankle brachial pressure index (ABPI), peripheral vascular
disease (PVD), heart rate variability (HRV), calcification, atherosclerosis
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Introduction
The evolution of complex systems may be characterized by
nonequilibrium phase transitions that lead to a divergence of
structure and function in biological systems (Haken, 1983).
Pathophysiological processes are multifactorial and character-
ized by chaotic dynamics where nonequilibrium phase transi-
tions may lead to new multiple stable states including diabetes,
chronic kidney disease or coronary artery disease, as well as
peripheral vascular disease (Glass, 2001). Physiological or patho-
physiological stable states may also include transient processes
occurring in neuronal, metabolic or vascular function such as
can be observed during the stages of sleep (Bashan et al., 2012).
Peripheral vascular disease (PVD) is characterized by changes
in structural and metabolic function in peripheral arteries and
arterioles, and is generally considered to be a predictor of car-
diovascular disease (CVD) and stroke (Thom et al., 2006). The
ankle-brachial pressure index (ABPI) provides a tool for identifi-
cation of patients at higher risk of adverse cardiovascular events
(Hirsch et al., 2005). ABPI values range from 0.5 to above 1.4 indi-
cating either arterial stenosis or vascular calcification (Jelinek and
Austin, 2006). This divergent pathophysiology hinges on changes
in metabolic processes such as oxidative stress (Loffredo et al.,
2007), where increased reactive oxygen species (ROS) have been
shown to have a causative role in atherosclerosis and vessel nar-
rowing, thus leading to a lower ABPI (Dröge, 2002; Madamanchi
et al., 2005). Different but overlapping metabolic processes are
involved in vessel calcification (Demer and Tintut, 2008; Rogers
and Aikawa, 2014). These subtle differences in metabolic pro-
cesses affecting blood constituents and the vessel walls can lead
to divergent stable states manifesting as arterial stenosis, which
is due to a narrowing of the arterial lumen, or vascular calcifica-
tion, which is characterized by arterial sclerosis. The autonomic
nervous system, which, regulates heart rate and vessel diameter,
is also affected by ROS through central or peripheral mecha-
nisms (Feldman, 2003; Ye et al., 2006). These neural processes
may then be coupled to different pathological stable states such
as arterial stenosis and vascular calcification (Figure 1). Figure 1
explores the effect of pathophysiological changes to a common
metabolic pathway regulating vascular and neural function such
as oxidative stress through increases in reactive oxygen species
(Feldman, 2003). When the physiological systems and metabolic
processes are in equilibrium, the interaction of diverse physiolog-
ical subsystems provide a stable functioning environment includ-
ing interactions between the peripheral vasculature and cardiac
rhythm (Madamanchi et al., 2005). This is depicted in the top
part of the figure. Oxidative stress is a manifestation of a changed
metabolic milieu, which in turn leads to divergent pathophysio-
logical functions as depicted in the lower half of the diagram illus-
trated as arterial stenosis, vessel calcification and arrhythmogenic
propensity. The physiological coupling between vascular and car-
diac function has changed and can be seen in a similar way that a
phase transition leads to new subsystems (Haken, 1983). Arterial
stenosis and vascular calcification can be viewed as two new sub-
systems, which are now differently coupled to cardiac rhythm.
That is arterial stenosis and low ABPI is now associated with a
reduced heart rate variability (HRV) and vessel calcification is
associated with increased HRV. Both increased and decreased
HRV, which may be associated with a decrease or increase in the
time and frequency domain HRV features or indicated by lower
or higher entropy as well as changes in short and long-term cor-
relations between RR intervals measured by DFA. Increased and
decreased HRV have been shown to increase the risk of adverse
cardiac events (Stein et al., 2005).
Individual divergent states are coupled to produce cooperative
states with other physiological systems including the cardiovas-
cular and renal systems. Investigating both the ABPI—a mea-
sure of peripheral vasculature patency and vessel wall stiffness,
and heart rate variability (HRV)—analysis of cardiac rhythm,
(Goernig et al., 2008; Deguchi et al., 2009; Jelinek et al., 2013)
may provide insight into the relationship of vascular networks
and their coupling with the autonomic nervous system.
HRV analysis is a simple, sensitive and non-invasive method
for measuring cardiac rhythm and refers to the beat-to-beat
variation in heart rate. It is the result of complex interactions
between the autonomic nervous system, endocrine influences,
vasomotor and respiratory centers (Kautzner and Camm, 1997;
Chandra et al., 2003). An increase or decrease in HRV typically
provides an indication of compromised cardiovascular health
and increased risk of cardiac morbidity and mortality (Task
Force, 1996; Pumprla et al., 2002).
In clinical practice, peripheral vascular function is most often
determined using the ankle brachial pressure index (ABPI). ABPI
measures the patency of blood vessels in the lower limbs. A lower
ABPI usually indicates arterial stenosis due to the formation of
atheromatous plaques in the vessel walls, whereas an elevated
ABPI indicates arterial sclerosis due to a more pronounced calci-
fication of the vessel wall. Based on the literature, normal values
for ABPI, independent of age and gender, should be above 0.9 and
below 1.3 (Rose, 2000; Brooks et al., 2001; McDermott McGrae
et al., 2003b). Results below this threshold indicate varying levels
of peripheral arterial stenosis. An ABPI over 1.3 indicates vessel
wall calcification. However, consensus on cut-off values for low
or high ABPI associated with pathology has not been reached,
and the normal range of ABPI values used in clinical practice
may range between 0.8 and 1.4 (Hiatt et al., 1995; Moffatt and
O’Hare, 1995; Rose, 2000; Brooks et al., 2001; Vowden and Vow-
den, 2001; McDermott McGrae et al., 2003a; Resnick et al., 2004;
McDermott et al., 2005; Austin et al., 2006; Jelinek and Austin,
2006). The prevalence of low ABPI in clinical practice typically
varies with age and presence of cardiovascular risk factors, rang-
ing from 2 to 29%. Coronary artery disease is present in approxi-
mately half of the individuals presenting with a low ankle brachial
pressure index (ABPI), based on ECG findings (Hirsch et al.,
2006). Conversely, the prevalence of vascular calcification, which
is more commonly associated with increased ABPI values, has
been reported to be between 1.1 and 6.3% depending on age and
the ABPI cut-off value chosen (Wattanakit et al., 2007; Allison
et al., 2008). The pathophysiological relationship between CVD
and high ABPI remains unknown, although many studies have
addressed the correlation between low ABPI and CVD (Cui et al.,
2014; Zhan et al., 2015). This may be in part due to the two differ-
ent, complex dynamic processes associated with the development
of arterial stenosis and vascular calcification.
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FIGURE 1 | Progression and divergence of peripheral vascular disease and HRV.
It is well established that CVD risk increases with decreased
or increased ABPI. In addition, CVD or coronary heart disease
mortality has been shown to be associated with abnormal heart
rate variability (HRV) (Huikuri, 1995; Voss, 2007; Jelinek et al.,
2013; Papaioannou et al., 2013).
Up to now no laboratory has investigated the changes in HRV
associated with both low ABPI (arterial stenosis) and high ABPI
(vascular calcification) and the effect on HRV. How pathologi-
cal changes to the metabolic network lead to different expres-
sions within the vascular networks, and how in turn these are
coupled with the cardiac network, requires further investigation.
Specifically, we address the metabolic/pathophysiological cou-
pling associated with arterial stenosis and vascular calcification
with respect to ABPI and HRV measures in our model.
Methods
Participant Recruitment
Participants were recruited as part of the Charles Sturt University
Allied Health Clinic diabetes complications screening program
(DiScRi). The study was approved by the local ethics committee.
No exclusion criteria were applied, with the exception of exclud-
ing records where the time series containedmore than 5% ectopic
beats.
Procedures and Instrumentation
Participants were rested for a minimum of 5min, in a supine
position on an examination plinth before measuring ABPI
and recording heart rate. Examination rooms were all of a
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comfortable temperature with minimal noise during the mea-
surements. Using a pressure cuff, sphygmomanometer and a
Doppler ultrasound unit (Hadeco ES-1000 SPII, Hayashi Denki
Co., Tokyo Japan) with an 8 MHz probe, systolic blood pressure
(SBP)measurements were obtained from each brachial artery and
each posterior tibial artery. The ABPI was calculated by dividing
the ankle blood pressure readings by the brachial blood pressure
readings to provide a normalized ratio. Mean ABPI scores for
each participant were calculated using the left and right foot ABPI
results (Brooks et al., 2001).
ECG recordings were made under standardized conditions
between 10 a.m. and 3 p.m. using a Powerlab recording system
(ADInstruments) and Chart™ software package (version 6). The
sampling frequency was set at 1000Hz, as recommended in the
literature (Task Force, 1996), and a 45Hz low-pass filter was used
to eliminate high frequency noise. Three disposable snap ECG
electrodes were placed onto the participant’s left hip bone, left
and right collar bones for a Lead II recoding configuration, as
this provided the best indication of the R peaks within the ECG.
All ECG signals went through a detailed manual editing process.
HRV analyses were performed on the 5-min ECG time series
using Kubios HRV analysis software (Tarvainen et al., 2014b).
Time domain analyses quantify the amount of variability in
heart rate time series derived from ECG recordings (Chandra
et al., 2003). The standard deviation of normal interbeat inter-
vals (SDNN), percentage of successive interbeat intervals dif-
fering more than 50ms (pNN50), the root mean square of the
standard deviation (RMSSD), and Poincaré Plot analysis, were
chosen as the time-domain indices. Frequency domain analysis
quantifies the underlying rhythms in an ECG signal. It parti-
tions the total variance of the heart rate into variance accounted
for by the underlying groups of frequencies: low frequency (LF
power: 0.04–0.15), which is representative of parasympathetic
and sympathetic influence, and high frequency (HF power: 0.15–
0.4Hz), representing parasympathetic influence. Total power as
well as the LF/HF ratio were also determined (Lombardi et al.,
1996). LFnu and HFnu are the LF power and HF power nor-
malized by total power (Task Force, 1996). The nonlinear mea-
sures included detrended fluctuation analysis (DFA), correlation
dimension (D2), and sample entropy (SampEn). Detrended fluc-
tuations analysis (DFA) quantifies the presence or absence of
complex correlation properties of the R–R intervals (Mäkikallio
et al., 2002). DFA α is the gradient of a spectrum of data and
can be divided into DFA α1, which is an index for short-term
(4–11 beats) correlations and DFA α2, which is an index for
longer (12–64 beats) correlations in an R-R interval time series
and outlined in detail at www.physionet.org (Peng et al., 1995).
Sample entropy (SampEn) quantifies the regularity and com-
plexity of time series data such as heart rate (Richman andMoor-
man, 2000). Large values of SampEn indicate high irregularity,
while smaller values of SampEn suggest a more regular signal.
Sample entropy (m, r, N) is an extension of the ApEn approach
developed by Grassberger and others (Grassberger, 1988) and is
defined similarly to ApEn. SampEn differs to ApEn in that in
SampEn self-comparisons of embedding vectors (RR sequences
of m = 2 or m = 3 beats) are excluded, whereas in ApEn every
embedding vector is compared also with itself. Second, SampEn
takes the logarithm of the sum of the probabilities rather than
the log of each probability. Third, SampEn is more robust for
smaller data sets (Richman and Moorman, 2000; Yentes et al.,
2013).
Statistics
A Kruskal-Wallis test followed by a post hoc Mann-Whitney
U-test were applied to the data following a test for homogeneity
(kurtosis > 2). Chi-square analysis was performed to determine
group differences for medication use. All data were analyzed
using SPSS Version 22 (IBM Pty). Statistical significance was
identified using p < 0.05.
Results
ABPI, HRV and demographic data, as well as additional clinical
data, was collected for 234 patients attending the diabetes com-
plications screening clinic at Charles Sturt University in Albury,
Australia. Using the ABPI range, the cut-off values for the lowest
and highest tertile were determined to be <1.07 and >1.23 and
were used to divide the participants into normal (n = 101), low
(n = 67) and high (n = 66) ABPI groups. Group demographics
are shown in Table 1.
There were no statistical significant differences between gen-
ders in any of the three groups. The group with lower ABPI were
slightly older, with a mean age of 63 years. However this differ-
ence was not significant. The low ABPI group also had a longer
history of DM, with an average duration of 4.5 years, and longer
duration of hypertension (p < 0.05). However the normal ABPI
group had the highest percentage of individuals with diabetes
type 2. Differences for systolic blood pressure (SBP) and ABPI
were significant between the three groups (p < 0.05).
TABLE 1 | Physiological differences in the cohort between those with
normal, low and high ABPI.
Normal ABPI Low ABPI High ABPI
n = 101 n = 67 n = 66
Gender (F/M) 57/44 39/28 33/33
Age (years) 61.4± 13.3 63± 12 59±11
Diabetes Type 2 (years) 4.7± 8 4.5± 6 2.26±5%
Diabetes Type 2 (%) 18.2 13.1 8.9
CVD (years) 0.6± 2.8 1.5± 4 0.4±2
HT (years) 3.4± 8.9 8.1± 12 3.2±8∗#
WC (cm) 93.53.4± 15.5 100.1± 18.4 96.1±12.7
BMI 28.7± 6.1 29.7± 6.6 28.3±5.5
SBP (mmHg) 133.8± 17.4 139.8± 18.6# 124.5±14∗%
DBP (mmHg) 79.6± 8.6 80± 10.1 76±9∗%
Average ABPI 1.16± 0.05 0.96± 0.1# 1.31±0.05∗%
∗p < 0.05 significant for low vs. high ABPI.
#p < 0.05 normal vs. low ABPI.
%p < 0.05 normal vs. high ABPI; CVD, cardiovascular disease reported; HT, hypertension
reported; WC,waist circumference; BMI, body-mass-index; SBP, systolic blood pressure;
DBP, diastolic blood pressure; ABPI, ankle-brachial-pressure-index. (Values in mean ±
standard deviation).
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TABLE 2 | Differences in measured blood chemistry between those with
normal, low and high ABPI.
Normal ABPI Low ABPI High ABPI
n = 101 n = 67 n = 66
BGL (mmol/L) 6.81±2.9 6.2± 1.9 6.1±2.9
HbA1c (%) 6.5±1.1 6.7± 1.2 6.1±0.8∗%
TC (mmol/L) 5.02±1 4.89± 1.05 5.1±1.4
Trigs (mmol/L) 1.41±0.9 1.46± 0.9 1.2±0.7
HDL (mmol/L) 1.49±0.5 1.51± 0.5 1.53±0.5
LDL (mmol/L) 2.89±0.9 2.7± 1 3±1.2
TC/HDL 3.6±1 3.5± 1.1 3.6±1.3
∗p < 0.05 is significant for low vs. high ABPI.
#p < 0.05 normal vs. low ABPI.
%p < 0.05 normal vs. high ABPI; BGL, blood glucose level; HbA1c, glycated hemoglobin;
TC, total cholesterol; Trigs, triglycerides; HDL, high density lipoprotein; LDL, low density
lipoprotein; TC/HDL, total cholesterol: high density lipoprotein ratio. (Values in mean ±
standard deviation).
Traditional biomarker results are presented in Table 2. These
indicate that only HbA1c was significantly higher in the low
ABPI group (Table 2). Cholesterol markers were within normal
limits but screening blood glucose levels were slightly elevated in
all three groups but not significantly different.
HRV results were divided into time domain, frequency
domain and non-linear parameters. The linear measures of
LF/HF ratio and LFnu were significantly decreased in the low
ABPI compared to the normal ABPI group. Normalized units of
low frequency power (LFnu) was lower in both the low ABPI
group as compared to the normal ABPI group, indicating a
possible reduced sympathovagal balance affecting the low ABPI
group more than the high ABPI group. Only the non-linear
parameters provided significant differences between the low and
high ABPI groups, as shown in Table 3 and Figure 2.
DFAα1 was significantly lower in the low ABPI group com-
pared to normal and high ABPI group. SampEn results were sig-
nificantly higher in the high ABPI as compared to the normal
group (Figure 3).
This result is also reflected in the low frequency to high fre-
quency ratio, which is lowest in the low ABPI group. However,
both LFnu and the LF/HF ratios were not significantly different
between the low and high ABPI group. None of the linear HRV
measures indicated a significant difference between the normal
and high ABPI group.
Figure 3 emphasizes that only the nonlinear parameters were
significantly different between the normal and high ABPI group
as well as between the low and high ABPI group.
Discussion
Network physiology provides a model for investigating com-
plex dynamic processes and interactions between physiologi-
cal systems that may lead to transitions and new steady states,
and enables a clearer understanding of pathophysiology. Self-
organizing systems emerging through phase transitions far from
equilibrium, have been discussed for various biological systems
(Horsthemke and Lefever, 1984; Erdi and Barna, 1985).
TABLE 3 | Differences in measured HRV between those with normal, low
and high ABPI.
Normal ABPI Low ABPI High ABPI
SDNN (ms) 40.7± 19 42.9±18.5 39.6± 16.6
RMSSD (ms) 28.1± 26.8 31.5±25.3 28.4± 19.2
pNN(50) (ms) 11.8± 18.3 9.9±13.7 10.4± 19.1
LF (ms2) 432.9± 573.8 432±519.5 430.5± 454.7
HF (ms2) 385.4± 819.2 419±630.7 413.6± 673.3
LFnu 57.4± 18 50.9±17.3# 53.6± 19.3
HFnu 41.5± 45.1 43±16.3 41.7± 18.4
LF/HF 2.3± 2.2 1.6±1.7# 2.1± 2.4
SD1 28.8± 25.7 28.7±24.6 22.4± 21.4
SD2 56.7± 4.42 54.2±21.1 49.6± 25.7
DFAα1 1.03± 0.3 0.91±0.28
# 1.02± 0.3∗
SampEn 1.3± 0.3 1.72±0.6 1.52± 0.3∗%
∗p < 0.05 is significant for low vs. high ABPI.
#p <0.05 normal vs. low ABPI.
%p < 0.05 normal vs. high ABPI; LF, low frequency power; HF, high frequency power;
LFnu, low frequency normalized units; HFnu, high frequency normalized units; LF/HF,
ratio of low frequency to high frequency power; DFAα1, short-term scaling for detrended
fluctuation analysis; SampEn, sample entropy. (Values in mean ± standard deviation).
Complex pathological metabolic processes are a natural input
that drive activity-dependent, self-organizing dynamic networks,
such as the peripheral vascular system and cardiovascular system,
toward transitions which lead to new, stable albeit pathological
forms.
The current work investigated the relationship between car-
diac autonomic neuropathy and PVD, in a clinical population
attending a diabetes complications clinic. Previous studies have
indicated a relationship between CVD and PVD, where PVD was
defined by a low ABPI (typically <0.9) (Rose, 2000; Brooks et al.,
2001; McDermott McGrae et al., 2003b). However, investigations
into the relationship between high ABPI and CVD, and whether
there is a different mechanism involved in the coupling between
arterial stenosis and CVD vs. vascular calcification and CVD,
have not been reported.
Peripheral vascular disease and ABPI are correlated with HRV
in people with cardiovascular disease, where HRV and ABPI val-
ues are both reduced (Goernig et al., 2008; Ahn and Kong, 2011).
Increased HRV, however, has also been suggested to be associated
with cardiovascular pathophysiology and this association was
further investigated in the current research. The current results
show that DFAα1 was decreased in the low ABPI group, as com-
pared to the normal ABPI group, indicting a loss of complexity
in HRV associated with arterial stenosis. The loss of complexity
is possibly associated with an overall change in sympathovagal
balance and the significant decrease observed in LFnu power.
DFAα1, although shown as being significantly different between
low and high ABPI, is similar to the DFAα1 values shown for
the normal ABPI group. Thus the pathophysiology of vascular
calcification in our group may not directly affect HRV complex-
ity. Entropy or disorder, however was significantly increased in
the high ABPI compared to normal ABBPI group when mea-
sured as SampEn. Both reduced or increased HRV may thus be
pathological and indicate different PVD pathology (Stein et al.,
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FIGURE 2 | Nonlinear HRV for normal, low and high APBI centile groups.
FIGURE 3 | Time and frequency domain HRV results comparing normal, low and high APBI groups.
2005) associated with arterial stenosis and vascular calcification.
The extreme but nonsignificant high value of SampEn seen for
the low ABPI compared to the normal ABPI group (Table 3) may
be due to the current data distribution or HRV results associated
with short-term recordings. However the high SampEn may
indeed reflect an increased disorder or a difference in regularity
of the two data sets (Mayer et al., 2014) and is in line with the
decreased complexity and decreased LFnu observed in the low
ABPI group. In a previous study of ours we report significant
decreased linear HRV being associated with cardiac autonomic
neuropathy and associated with a significant increase in nonlin-
ear HRV measures (Tarvainen et al., 2014a). Nonlinear measures
of heart rate variability have been shown to be more sensitive
in describing the fractal-like, nonlinearity characteristics of the
cardiovascular system (Voss et al., 2009). The current results
extend the finding that reduced and elevated ABPI correlate with
significant changes in autonomic nervous system modulation
of the heart (Vowden and Vowden, 2001; Rabkin et al., 2012).
A correlation between ABPI and nonlinear HRV measures
has also been shown (Jelinek et al., 2013). The current study
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reports a significant difference in nonlinear DFAα1, and SampEn
parameters between the low and high ABPI group. Our current
findings demonstrate that the relationship between heart rate
variability, as an indicator of cardiac rhythm, and ABPI depends
on whether PVD is defined as arterial stenosis (low ABPI) or
vascular calcification (high ABPI). Additionally, our results show
that HRV is significantly different between the arterial stenosis
group and the vascular calcification group. This finding suggests
that the pathophysiological state of the peripheral vascular and
cardiac networks is driven by complex interactions including
metabolic processes such as oxidative stress and inflammation.
This pathological oxidative stress and/or inflammatory response,
leading to either arterial stenosis or vascular calcification also
leads to different transitions observed in the heart rate modulated
by the ANS. In our data, the development of arterial stenosis and
a decreased ABPI, or vascular calcification and elevated ABPI
values indicates a possible coupling of the heart rhythm with the
state of the peripheral vasculature.
The cut-off value for ABPI, indicating the presence of arterial
stenosis, typically range from 0.8 to 1.1 (Hiatt et al., 1995; Moffatt
and O’Hare, 1995; Rose, 2000; Brooks et al., 2001; Vowden and
Vowden, 2001; McDermott McGrae et al., 2003b). An ABPI of
less than 0.90 has been reported to be 95% sensitive and between
50 and 99% specific for angiographic significant arterial stenosis
(Applegate, 1993; Olin, 1998). Calcification, however, has been
shown to be associated with an ABPI greater than 1.2, although
some authors have suggested 1.3 or 1.4 as a cut-off threshold
(Jelinek and Austin, 2006; Jelinek et al., 2013; Nashar and Egan,
2014). Both arterial stenosis and non-compressible vascular dis-
ease have been previously reported to be associated with higher
CVD risk (Di Carli et al., 1999; Lise et al., 2006; Belch et al., 2008;
Pop-Busui et al., 2010; Mels et al., 2014).
The clinical use of HRV and ABPI as quantitative measures
assumes not only that these tests assessing diabetic neuropathy
and hemodynamic function respectively, are correlated, but also
that the pathophysiology has either certain common or disparate
features. The autonomic nervous system modulates heart rate
and also vessel patency. Hence autonomic neuropathy affects the
regulation of both blood flow and heart rhythm (Thomas, 2011).
Additionally, pathophysiological processes including inflamma-
tion and oxidative stress, which affect the autonomic nervous
system and endothelial cell function, play a role in disease pro-
gression and presentation (Al-Aubaidy and Jelinek, 2014; Laiti-
nen et al., 2014). We investigated whether HRV was significantly
different when ABPI was reduced or elevated outside the nor-
mal range. Our findings indicate that the interaction between
cardiac autonomic neuropathy and vascular dysfunction is multi-
factorial and differs depending on the pathophysiology associated
with PVD.
Network physiology provides a model for understanding
complex, nonlinear dynamics associated with the development
of discrete vascular and cardiac pathologies as self-organizing
networks, which are linked by various functional coupling and
feedback interactions through metabolic and neural networks
(Bashan et al., 2012). Here we propose that possible pathological
changes reported previously manifest as changes in the redox
balance of the network. The change in the redox milieu can lead
to perturbations in the neural and vessel subsystems/networks
and to transitions in function as new steady-state topologies of
the networks. Here we describe the transition from a balanced
multicomponent network (vascular and cardiac) within a
complex metabolic domain to new alternative topologies of these
networks. Hence arterial stenosis (low ABPI) and vascular cal-
cification (high ABPI) and become associated with low and high
HRV respectively. Low and high HRV values indicate pathology
and an increased risk of adverse cardiac events (Stein et al.,
2005). Our current findings however indicate that linear and
nonlinear HRV measures are sensitive to different characteristics
of the RR time series. The possible coupling observed for the
vascular and cardiac multistable states may be due to changes in
the functional coupling and bidirectional feedback mechanisms
associated with the vascular and cardiac networks (Bartsch et al.,
2012; Kelso, 2012).
The emphasis of this paper is to describe a novel interaction
between subnetworks that manifest as different clinical patholo-
gies and to propose a model based on network physiology, which
describes the transitions in these networks. Future work will ana-
lyze continuous data from normal, low and high ABPI individ-
uals utilizing Doppler ultrasound technology and will investi-
gate the coupling with HRV, determined from ECG recordings
of 30–120min duration, in order to enhance our understanding
of the coupling mechanisms.
Conclusion
Presence of CVD risk based on HRV showed an association with
nonlinear HRV measures, which differentiated between the low
and high ABPI group. This suggests that a link between both
arterial stenosis or vascular calcification, and heart disease, does
indeed exist. These findings may be described by a network phys-
iology model that is based on phase transitions occurring due to
system perturbations, coupling strengths and feedback mecha-
nisms that drive dynamic processes to new and different steady
states. In addition to shedding light on the complex etiology
of PVD through a network physiology framework, the results
obtained in this study can be used toward establishing more sen-
sitive diagnostic assessment measures as related to cardiovascular
health and functionality.
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